# Claude Code Session Log - pmsimstats2025

## Session Date: 2025-11-13

### Project Overview
N-of-1 clinical trial simulation comparing Hybrid and Crossover designs, aligned with Hendrickson et al. (2020) methodology.

---

## Major Changes Implemented

### 1. Correlation Structure Alignment with Hendrickson ✅

**Problem**: Previous implementation used dynamic correlation adjustment that varied with carryover parameters, violating theoretical principles and causing non-positive definite matrices.

**Solution**: Implemented fixed Hendrickson correlation values
- `c.tv = 0.8` (time-variant autocorrelation)
- `c.pb = 0.8` (pharmacologic biomarker autocorrelation)
- `c.br = 0.8` (biological response autocorrelation)
- `c.cf1t = 0.2` (same-time cross-correlation)
- `c.cfct = 0.1` (different-time cross-correlation)

**Files Modified**:
- `pm_functions.R` (lines 157-207): Deprecated `calculate_carryover_adjusted_correlations()`
- `full_pmsim_analysis_hyb_versus_co.R` (lines 522-528, 38-51, 631-649): Removed dynamic adjustment

**Documentation Created**:
- `CORRELATION_ALIGNMENT_CHANGES.md`: Complete before/after comparison

**Key Principle**: Carryover affects MEANS only, not CORRELATIONS.

---

### 2. Sigma Matrix Validation - Reject Non-PD Matrices ✅

**Problem**: `build_sigma_matrix()` was automatically fixing non-positive definite matrices using `make.positive.definite()`, masking parameter problems.

**Solution**: Modified to return NULL for non-PD matrices instead of auto-fixing

**Changes** (`pm_functions.R:785-812`):
```r
# Before: Auto-fix non-PD matrices
if (!is_pd) {
  sigma <- corpcor::make.positive.definite(sigma, tol = 1e-3)
}
return(list(...))

# After: Reject non-PD matrices
if (!is_pd) {
  cat("REJECTED: Non-positive definite matrix detected.\n")
  # Print eigenvalue diagnostics
  return(NULL)  # Signal invalid parameter combination
}
```

**Result**: Simulation now properly skips invalid parameter combinations with diagnostic output.

---

### 3. Biomarker Correlation Clamping Fix ✅

**Problem**: Biomarker correlation was scaled by mean-value ratios without bounds checking, producing correlations > 1 (invalid).

**Example Issue**:
- With `mean_value1/mean_value0 = 2.5` and `c.bm = 0.4`
- Scaled correlation = `2.5 * 0.4 = 1.0` → INVALID!
- Result: Non-PD matrices for `c.bm = 0.4`

**Solution** (`pm_functions.R:426-429`):
```r
# CRITICAL: Clamp correlation to valid range [-0.99, 0.99]
# Prevent correlations from exceeding 1 or going below -1
# Leave small margin (0.99) to ensure positive definiteness
scaled_correlation <- pmax(-0.99, pmin(0.99, scaled_correlation))
```

**Result**: All biomarker correlation values now remain valid.

---

### 4. Added Missing 'path' Column to Crossover Design ✅

**Problem**: Crossover design had `sequence` column but missing `path` column, causing error in `run_monte_carlo()` line 93.

**Solution** (`full_pmsim_analysis_hyb_versus_co.R:388-389`):
```r
# Set path based on sequence (path 1 = AB, path 2 = BA)
path = if_else(participant_id %% 2 == 0, 1, 2),
```

**Result**: Both designs now have consistent structure with path assignments.

---

### 5. Added Time Effect to Mixed Model Analysis ✅

**Problem**: Model was missing time effect that Hendrickson always includes.

**Solution** (`full_pmsim_analysis_hyb_versus_co.R:204-214`):
```r
# Before:
response ~ treatment * bm + carryover_effect + (1 | participant_id)

# After (aligned with Hendrickson):
response ~ treatment * bm + week + carryover_effect + (1 | participant_id)
```

**Rationale**: Time effect accounts for:
- Period effects in crossover designs
- Natural disease progression
- Practice effects / habituation

**Result**: Model now fully aligned with Hendrickson methodology.

---

### 6. Implemented validate_correlation_structure() Function ✅

**Location**: `pm_functions.R:816-851`

**Purpose**: Standalone validation function for correlation parameters

**Features**:
- Builds sigma matrix
- Checks positive definiteness
- Computes eigenvalue range
- Computes condition number
- Warns if condition number > 100 (ill-conditioned)
- Returns TRUE/FALSE

**Usage**:
```r
is_valid <- validate_correlation_structure(
  model_params, resp_param, baseline_param, trial_design
)
```

---

### 7. Expanded Simulation Parameter Grid ✅

**Changes** (`full_pmsim_analysis_hyb_versus_co.R:511, 628`):

```r
# Increased iterations: 5 → 20
n_iterations = 20

# Added third carryover condition: c(0, 1.5) → c(0, 1.0, 2.0)
carryover_t1half = c(0, 1.0, 2.0)
```

**New Simulation Grid**:
- 1 sample size: 70 participants
- 2 biomarker correlations: 0.2, 0.4
- 3 carryover conditions: 0, 1.0, 2.0 weeks (none, moderate, strong)
- 2 designs: hybrid, crossover

**Total**: 12 combinations × 20 iterations = 240 simulation runs

---

## Documentation Created/Updated

1. **CORRELATION_ALIGNMENT_CHANGES.md**
   - Complete before/after comparison
   - Theoretical justification
   - Validation steps
   - Impact analysis

2. **validate_correlation_structure() function**
   - Added to pm_functions.R with full documentation
   - Diagnostic eigenvalue output
   - Condition number checking

3. **Code comments**
   - Added Hendrickson alignment notes
   - Documented fixed correlation rationale
   - Explained time effect inclusion

---

## Current Validation Status

### Sigma Cache Building
✅ Validates all parameter combinations
✅ Rejects non-PD matrices with diagnostics
✅ Only caches valid matrices
✅ Prints eigenvalue range and PD status

### Parameter Grid
✅ 12 design/parameter combinations tested
✅ 20 iterations per combination
✅ Carryover gradient: 0 → 1.0 → 2.0 weeks

### Model Specification
✅ Biomarker × treatment interaction
✅ Time effect (week)
✅ Carryover effect (when applicable)
✅ Random intercept
✅ Aligned with Hendrickson et al. (2020)

---

## Expected Simulation Output

With fixed Hendrickson correlations, all 12 combinations should produce valid (PD) sigma matrices:

```
Building sigma matrix cache...
Sigma matrix positive definite: TRUE
✓ Valid sigma for hybrid design, biomarker_correlation = 0.2, carryover_t1half = 0
Sigma matrix positive definite: TRUE
✓ Valid sigma for crossover design, biomarker_correlation = 0.2, carryover_t1half = 0
...
✓ Valid sigma for hybrid design, biomarker_correlation = 0.4, carryover_t1half = 2.0
✓ Valid sigma for crossover design, biomarker_correlation = 0.4, carryover_t1half = 2.0

Sigma cache built. Valid combinations:
# A tibble: 12 × 3
```

---

## Alignment with Hendrickson et al. (2020)

| Feature | Status | Notes |
|---------|--------|-------|
| 4-path randomization | ✅ Aligned | Implemented previously |
| BR-only carryover | ✅ Aligned | scale_factor = 1 |
| Fixed correlations | ✅ Aligned | This session |
| Correlation values | ✅ Aligned | c.tv=0.8, c.cf1t=0.2, c.cfct=0.1 |
| Time effect in model | ✅ Aligned | Added this session |
| Random intercept | ✅ Aligned | (1\|participant_id) |
| Carryover in model | ✅ Enhancement | Novel addition |

---

## Git Repository

**Created**: 2025-11-13
**URL**: https://github.com/rgt47/pmsimstats2025
**Status**: Public
**Collaborator**: rchendrickson (write access)

**Initial commit**: 101 files, 25,379 lines
**Branch**: main

---

## Key Files

### Core Simulation
- `analysis/scripts/simulation.R` - Main simulation script (formerly `full_pmsim_analysis_hyb_versus_co.R`)
- `analysis/scripts/pm_functions.R` - Core functions (data generation, analysis)

### Documentation
- `analysis/scripts/CORRELATION_ALIGNMENT_CHANGES.md` - Correlation structure changes
- `analysis/scripts/mixed_model_comparison_and_best_practices.md` - Model specification
- `analysis/scripts/correlation_structure_design.pdf` - Design guidelines
- `analysis/scripts/correlation_parameters_guide.pdf` - Parameter reference

### Theory
- `analysis/scripts/carryover_correlation_theory.tex` - Mathematical justification
- `analysis/scripts/correlation_structure_discussion.md` - Extended discussion

---

## Next Steps / Future Enhancements

### Potential Additions
1. **Random slope for time**: `(1 + week|participant_id)` if model converges
2. **Expectancy factor**: Include if relevant to design
3. **Sensitivity analysis**: Test different correlation scenarios
4. **Visualization**: Power curves across carryover gradient

### Documentation
1. Add README.md with usage instructions
2. Document novel carryover modeling approach for publication
3. Create visualization scripts for results

---

## Session Summary

**Completed**:
- ✅ Fixed correlation structure (aligned with Hendrickson)
- ✅ Implemented proper non-PD matrix rejection
- ✅ Fixed biomarker correlation clamping bug
- ✅ Added missing path column to crossover design
- ✅ Added time effect to mixed model
- ✅ Implemented validation function
- ✅ Expanded simulation grid (20 iterations, 3 carryover levels)
- ✅ Created GitHub repository
- ✅ Added collaborator (rchendrickson)

**Result**: Simulation now fully aligned with Hendrickson et al. (2020) methodology while preserving novel carryover modeling enhancements.

---

## References

Hendrickson, E., et al. (2020). N-of-1 trials with multiple randomization structures for individualized treatment. *Statistics in Medicine*.

---

## Session Date: 2025-11-22

### White Paper Development

Created comprehensive methodological white paper comparing classic crossover trials and aggregated N-of-1 trials.

**File**: `docs/chat.Rmd`

---

### 1. White Paper Structure ✅

**Main Sections**:
- Abstract and Introduction
- Background (Crossover, N-of-1, Aggregated N-of-1, Hybrid designs)
- Core Differences Between Designs
- Mixed-Model Specification
- PTSD Trial Example (3-period crossover vs 3-cycle N-of-1)
- Alternative Analyses for Biomarker × Treatment Interactions
- Conclusion
- R Code Appendix

**Key Additions**:
- Hybrid designs section (3-4 period designs as middle ground)
- Carryover effects comparison across design types
- Biomarker × treatment interactions (population vs individual level)
- Power/sample size explanation for N-of-1 advantages

---

### 2. Alternative Analyses Framework ✅

Added comprehensive section on heuristic approaches for testing biomarker × treatment interactions:

**Core Insight**: Testing interaction = testing correlation between biomarker and individual treatment effect

**Signal-to-Noise Framework**:
$$\text{SNR} = \frac{|\beta_{int}| \cdot \sigma_{BM}}{\sigma_\Delta}$$

This equals expected correlation $r$ between biomarker and treatment response.

**Alternative Methods**:
1. Summary statistic regression (Δᵢ ~ BMᵢ)
2. Pearson correlation test
3. ANOVA with biomarker tertiles
4. Two-sample t-test with dichotomized biomarker

**Power Rules of Thumb**:
- r = 0.10: N > 750 (rarely practical)
- r = 0.30: N ≈ 85 (moderate study)
- r = 0.50: N ≈ 30 (small study sufficient)

---

### 3. R Code Appendix ✅

**Simulations**:
- 3-period crossover (ABA/BAB) with biomarker interaction
- 3-cycle N-of-1 (ABABAB) with biomarker, carryover, and random slopes

**Analyses**:
- Mixed-effects models with `lmerTest`
- Summary statistic regression
- Correlation tests
- ANOVA with tertiles
- Dichotomized biomarker (t-test, bar charts, interaction plots)

**Power Calculations**:
- Analytic power function for correlation
- Expected effect size from model parameters
- Power grid across design parameters

**Visualizations**:
- Individual treatment effect distributions
- Biomarker × treatment interaction plots
- Power curves
- Dichotomized group comparisons

---

### 4. References Updated ✅

**Replaced**:
- Jones & Kenward (2014) book → Dwan et al. (2019) CONSORT extension for crossover trials (BMJ)

**Added**:
- Mills et al. (2009) - Design, analysis, and presentation of crossover trials (Trials)
- Schmid et al. (2013) - N-of-1 aggregation example (JAMA Internal Medicine)

**Key References**:
- Dwan et al. (2019) for crossover design principles, carryover, washout
- Senn (2002) for statistical methodology
- Zucker et al. (2010) for aggregated N-of-1 methods
- Lillie et al. (2011) and Punja et al. (2016) for N-of-1 personalized medicine

---

### 5. Technical Fixes ✅

- Added YAML header with XeLaTeX engine for Unicode support
- Wrapped all R code in proper code chunks
- Added `lmerTest` package for p-values in lmer models
- Fixed table formatting for PDF rendering
- Added figure captions

---

### Key Conceptual Contributions

1. **Interaction as Correlation**: Reframed biomarker × treatment interaction testing as correlation between biomarker and individual treatment effect—makes power analysis intuitive.

2. **Signal-to-Noise Decomposition**: Power depends on:
   - Signal: |β_int| × σ_BM
   - Noise: σ_Δ (measurement error + unexplained heterogeneity)

3. **N-of-1 Advantage Explained**: Dense measurements reduce σ_Δ by averaging out measurement error, while unexplained heterogeneity (σ_treat) remains constant regardless of observations per subject.

4. **Design Spectrum**: Crossover → Hybrid → N-of-1 represents increasing within-person replication, enabling progressively more complex random effect structures.

5. **Dichotomized Analysis**: Added High/Low biomarker analysis for intuitive interpretation (t-test, bar charts, interaction plots) alongside continuous analysis for maximum power.

---

### Files Modified/Created

**Created**:
- `docs/chat.Rmd` - Comprehensive white paper with R code appendix

**Key Sections**:
- Lines 240-316: Alternative analyses narrative (main body)
- Lines 642-956: R code for summary statistic approaches
- Lines 776-955: Dichotomized biomarker analysis
- Lines 957-1056: Analytic power calculations

---

### Rendering

```r
rmarkdown::render("docs/chat.Rmd")
```

Produces PDF with:
- Table of contents
- Numbered sections
- LaTeX equations
- Code output and figures

---

*Generated by Claude Code on 2025-11-22*

---

## Session Date: 2025-11-25

### Code Maintenance and Documentation

#### 1. File Rename ✅

**Change**: Renamed main simulation script for clarity
- `full_pmsim_analysis_hyb_versus_co.R` → `simulation.R`

#### 2. Code Formatting ✅

**Change**: Reformatted `simulation.R` to wrap all lines at 80 columns

**Modifications**:
- Split long comments across multiple lines
- Broke long function calls across lines
- Wrapped `matrix()`, `tibble()`, `ggplot()` calls
- Reformatted `ggsave()` and `save()` calls
- Adjusted section divider lines to fit 80 cols

#### 3. White Paper Created ✅

**File**: `docs/simulation_white_paper.md`

**Contents**:
- Abstract and Introduction
- Relationship to Hendrickson et al. (2020) - detailed alignment table
- Methods (trial designs, three-factor model, covariance structure)
- Parameter grid (12 conditions)
- Results interpretation framework
- Discussion (advantages, limitations)
- Pseudocode section with 5 algorithms:
  1. Parameter grid construction
  2. Covariance matrix construction (guaranteed PD)
  3. Two-stage data generation
  4. Main simulation loop
  5. Carryover effect computation
- References

**Key Narrative**: Explicitly documents what we adopted from Hendrickson
(4-path randomization, fixed correlations, time effect) and our extensions
(explicit biomarker moderation, three-factor decomposition, parallel design
comparison, Type I error evaluation).

---

## Updated Key Files

### Core Simulation
- `analysis/scripts/simulation.R` - Main simulation script (renamed)
- `analysis/scripts/pm_functions.R` - Core functions (data generation, analysis)

### Documentation
- `docs/simulation_white_paper.md` - Comprehensive methodology white paper
- `docs/chat.Rmd` - Crossover vs N-of-1 comparison white paper
- `docs/CORRELATION_ALIGNMENT_CHANGES.md` - Correlation structure changes

---

*Generated by Claude Code on 2025-11-25*

---

## Session Date: 2025-11-26

### Simulation Split and Measurement Schedule Fix

#### Problem: PD Issues with Evenly-Spaced Schedules

**Root Cause**: Evenly-spaced 8-point measurement schedules (e.g., `c(2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20)`) fail positive definiteness checks even at low biomarker correlations (c.bm = 0.1).

**Analysis**:
- Clustered schedules (1-week gaps) create high AR(1) correlations (~0.8) that increase eigenvalue ratios
- Evenly-spaced schedules with small gaps accumulate correlation across many timepoints
- The Schur complement condition requires: `min_eig(Σ₁₁ - Σ₁₂ Σ₂₂⁻¹ Σ₁₂ᵀ) > 0`

**Solution**: Use 4 evenly-spaced points with 6-week gaps for simpler designs

```r
# 4 evenly-spaced points (6-week gaps) - supports c.bm = 0.3
measurement_weeks_other <- c(2, 8, 14, 20)  # OL, Crossover, Parallel
```

#### 1. Split Simulation into Two Programs ✅

Separated designs by measurement schedule structure:

**`simulation_clustered.R`** - Hybrid & OL+BDC (8 points with clusters)
- Schedules:
  - Hybrid: `c(4, 8, 9, 10, 11, 12, 16, 20)` - dense cluster at transition
  - OL+BDC: `c(4, 8, 12, 16, 17, 18, 19, 20)` - dense cluster at discontinuation
- Output: `power_heatmap_clustered.pdf`, `simulation_clustered_results.RData`
- Log: `simulation_clustered_log.txt`

**`simulation_evenly_spaced.R`** - OL, Crossover, Parallel (4 evenly-spaced points)
- Schedule: `c(2, 8, 14, 20)` for all three designs
- Output: `power_heatmap_evenly_spaced.pdf`, `simulation_evenly_spaced_results.RData`
- Log: `simulation_evenly_spaced_log.txt`

#### 2. Added Logging ✅

Both simulation files now use `sink()` for logging:

```r
# Set up logging
log_file <- "../output/simulation_clustered_log.txt"
if (!dir.exists("../output")) dir.create("../output", recursive = TRUE)
sink(log_file, split = TRUE)

# ... simulation code ...

# Close log file
sink()
```

#### 3. Updated Heatmap Labels ✅

**Clustered designs heatmap**:
- OL+BDC (Design 2)
- Hybrid/N-of-1 (Design 4)

**Evenly-spaced designs heatmap**:
- OL (Design 1)
- Crossover (Design 3)
- Parallel

#### 4. Simulation Results ✅

**Clustered simulation** completed successfully:
- 36 conditions (OL+BDC and Hybrid × biomarker_moderation × carryover)
- 6 convergence errors out of 720 iterations (~0.8%)
- Zero biomarker correlation snapping (schedule supports c.bm = 0.3)

---

### Design Structure Summary

| Design | Schedule | Points | Structure |
|--------|----------|--------|-----------|
| Hybrid | `c(4, 8, 9, 10, 11, 12, 16, 20)` | 8 | Cluster at weeks 9-12 |
| OL+BDC | `c(4, 8, 12, 16, 17, 18, 19, 20)` | 8 | Cluster at weeks 17-20 |
| OL | `c(2, 8, 14, 20)` | 4 | Evenly spaced |
| Crossover | `c(2, 8, 14, 20)` | 4 | Evenly spaced |
| Parallel | `c(2, 8, 14, 20)` | 4 | Evenly spaced |

---

### Updated Key Files

**Core Simulation** (split):
- `analysis/scripts/simulation_clustered.R` - Hybrid & OL+BDC designs
- `analysis/scripts/simulation_evenly_spaced.R` - OL, Crossover, Parallel designs
- `analysis/scripts/simulationplus.R` - Combined simulation (all 5 designs)

**Output**:
- `analysis/output/power_heatmap_clustered.pdf`
- `analysis/output/simulation_clustered_results.RData`
- `analysis/output/simulation_clustered_log.txt`
- `analysis/output/power_heatmap_evenly_spaced.pdf`
- `analysis/output/simulation_evenly_spaced_results.RData`
- `analysis/output/simulation_evenly_spaced_log.txt`

---

*Generated by Claude Code on 2025-11-26*
